Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 2/20 | 0.45 |
| ▸ | PRKAG1 | P54619 | 15/20 | 0.42 |
| ▸ | PRKAA2 | P54646 | 15/20 | 0.42 |
| ▸ | PRKAB1 | Q9Y478 | 15/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | EBP | Q15125 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10698012 | 0.88 | HMGCR (0.54) | HMGCRPTPN1 | |
| SCHEMBL9769592 | 0.88 | HMGCR (0.54) | HMGCRPTPN1 | |
| SCHEMBL9769593 | 0.88 | HMGCR (0.54) | HMGCRPTPN1 | |
| SCHEMBL9769614 | 0.82 | HMGCR (0.46) | HMGCREBP | |
| SCHEMBL9769594 | 0.80 | HMGCR (0.49) | HMGCRPTPN1 | |
| SCHEMBL9769587 | 0.80 | HMGCR (0.49) | HMGCRPTPN1 | |
| SCHEMBL10697421 | 0.78 | HMGCR (0.38) | HMGCRPRKAG1PRKAA2PRKAB1PTPN1 | |
| SCHEMBL9766817 | 0.74 | HMGCR (0.53) | HMGCRPRKAG1PRKAA2PRKAB1PTPN1 | |
| SCHEMBL9766813 | 0.74 | HMGCR (0.53) | HMGCRPRKAG1PRKAA2PRKAB1PTPN1 | |
| SCHEMBL9766823 | 0.73 | HMGCR (0.52) | HMGCRPTPN1EBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0276823-A2 | 14,15-Substituted lanosterols and their use as hypocholesterolemic agents | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1988-08-03 | — | — | EP | disclosed |